Mesirow Financial Investment Management, Inc. Kala Pharmaceuticals, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

  • $4.94 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021
SELL
$2.62 - $5.43 $110,312 - $228,624
-42,104 Closed
0 $0
Q2 2021

Jul 23, 2021
BUY
$5.06 - $8.15 $723 - $1,165
143 Added 0.34%
42,104 $223,000
Q1 2021

Apr 14, 2021
SELL
$6.24 - $9.58 $9,172 - $14,082
-1,470 Reduced 3.38%
41,961 $283,000
Q4 2020

Jan 14, 2021
BUY
$6.28 - $8.79 $43,872 - $61,406
6,986 Added 19.17%
43,431 $294,000
Q3 2020

Oct 13, 2020
BUY
$7.5 - $11.11 $273,337 - $404,903
36,445 New
36,445 $273,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $11.7M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email